Prior to this study there were few data available on the interaction of selenoprotein genotype and Se status regarding CRC risk, apart from a study in a Se replete population of North American women which reported that the null results for serum Se did not differ by selenoenzyme (GPX1-4 and SELENOP) genetic variants [17]. This evidence concerns the gene SELENOS and colorectal carcinoma.